Medicine for treating chronic obstructive pulmonary disease during stable period and preparation method of medicine

A technology for chronic obstructive pulmonary disease and stable period, which is applied in the direction of drug combination, medical formula, respiratory system diseases, etc. It can solve the problems of decreased quality of life, malnutrition of the body, and difficult recovery of the disease, so as to improve the prognosis, the effect has no side effects, significant effect

Inactive Publication Date: 2015-04-08
QINGDAO MUNICIPAL HOSPITAL
View PDF1 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Traditional Chinese medicine believes that in the stable stage of COPD, there are deficiencies in the lung, spleen, and kidney. If the lung qi is deficient, the defense will not be strong and it will be easily invaded by evils. Therefore, the evils of the six evils repeatedly attack the lungs and induce the occurrence of this disease; If the child consumes the mother's qi, the spleen will lose its function, the stomach will not be well received, the body will be malnourished, the respiratory muscles will be fatigued, and the conditi

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating chronic obstructive pulmonary disease during stable period and preparation method of medicine
  • Medicine for treating chronic obstructive pulmonary disease during stable period and preparation method of medicine
  • Medicine for treating chronic obstructive pulmonary disease during stable period and preparation method of medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] A kind of medicine for the treatment of chronic obstructive pulmonary disease stable phase, by weight, its specific component content is as follows:

[0039] 30 parts of Astragalus, 20 parts of Polygonatum, 15 parts of Adenophora, 15 parts of Aster, 15 parts of Dilong, 10 parts of Inula, 20 parts of Albizia Julibrissin, 15 parts of Salvia, 15 parts of Chuanxiong, 10 parts of fried silkworm, 15 parts of Poria cocos 10 parts, 10 parts of ginger pinellia, 10 parts of licorice, 20 parts of Atractylodes macrocephala, 15 parts of epimedium, and 20 parts of rhodiola.

[0040] The specific preparation method is as follows:

[0041]1), weigh Radix Astragali, Rhizoma Polygonatum, Radix Glycyrrhizae, Aster, Inulae Inulae, Cortex Albizia Julibrissin, Salvia Miltiorrhiza, Rhizoma Chuanxiong, Poria, Pinellia Ginger, Radix Glycyrrhizae, Atractylodes Rhizome, Epimedium, Rhodiola plus 13~ Decoct 17 times the weight in water for 2.5 to 3.5 hours, filter and centrifuge to remove the slag...

Embodiment 2

[0043] A medicine for treating stable chronic obstructive pulmonary disease, in said pharmaceutical composition, by weight, its specific component content is as follows:

[0044] 30 parts of Radix Astragali, 20 parts of Polygonatum, 20 parts of Adenophora, 15 parts of Aster, 15 parts of Dilong, 12 parts of Inula, 20 parts of Albizia Julibrissin, 20 parts of Salvia, 15 parts of Chuanxiong, 12 parts of fried silkworm, 20 parts of Poria cocos 12 parts, 12 parts of ginger pinellia, 9 parts of licorice, 20 parts of Atractylodes macrocephala, 20 parts of epimedium, and 20 parts of rhodiola.

[0045] Concrete preparation method is with embodiment 1.

Embodiment 3

[0047] A medicine for treating stable chronic obstructive pulmonary disease, in said pharmaceutical composition, by weight, its specific component content is as follows:

[0048] 50 parts of Radix Astragali, 30 parts of Polygonatum, 12 parts of Adenophora, 20 parts of Aster, 20 parts of Dilong, 15 parts of Inula, 20 parts of Albizia Julibrissin, 15 parts of Salvia, 12 parts of Chuanxiong, 12 parts of fried silkworm, 20 parts of Poria cocos 15 parts of ginger pinellia, 12 parts of licorice, 30 parts of Atractylodes macrocephala, 12 parts of epimedium, and 20 parts of rhodiola.

[0049] Concrete preparation method is with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a medicine for treating chronic obstructive pulmonary disease during stable period and a preparation method of the medicine. The medicine is prepared from astragalus membranaceus, polygonatum kingianum, radix glehniae, aster, earthworm, inula flower, cortex albiziae, salviae miltiorrhizae, ligusticum wallichii, bombyx batryticatus, poria cocos, ginger processed pinellia, honey-fried licorice root, rhizoma atractylodis macrocephalae, epimedium and rhodiola rosea. The medicine has the effects of strengthening spleen, freeing lung, tonifying kidney, regulating qi, eliminating phlegm, removing stasis, relieving cough and asthma, resolving depression and calming, can be used for achieving the effect of treating both symptoms and root cause of the chronic obstructive pulmonary disease during stable period, improving lung functions, relieving clinical symptoms and improving the living quality and prognosis of patients in the chronic obstructive pulmonary disease during stable period. The medicine composition has remarkable effect and no side effect on treatment of the chronic obstructive pulmonary disease during stable period.

Description

technical field [0001] The invention relates to a traditional Chinese medicine formula, a medicine for treating chronic obstructive pulmonary disease, especially a medicine for treating chronic obstructive pulmonary disease in stable stage. Background technique [0002] Chronic obstructive pulmonary disease (COPD) is a disease characterized by airflow limitation, which is not fully reversible and progressive, and is associated with an abnormal inflammatory response of the lungs to noxious gases or particles. COPD primarily affects the lungs, but can also cause systemic (or extrapulmonary) adverse effects. The main clinical manifestations of COPD are cough, sputum, and dyspnea. Acute exacerbations often occur during the course of the disease, and acute exacerbations are the main factors that promote the continuous progression of the disease. COPD belongs to the category of "lung inflation" in traditional Chinese medicine. Physicians of past dynasties described the main symp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8969A61P11/00A61K35/62A61K35/64
CPCA61K36/481A61K35/62A61K36/076A61K36/23A61K36/236A61K36/28A61K36/284A61K36/296A61K36/41A61K36/48A61K36/484A61K36/537A61K36/8888A61K36/8969A61K2236/331
Inventor 宫巧俐张苗海侯晓群张向农
Owner QINGDAO MUNICIPAL HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap